Titan Medical Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.45 million. Net income was USD 0.068 million compared to net loss of USD 10.37 million a year ago.
For the nine months, sales was USD 17.13 million. Net income was USD 10.2 million compared to net loss of USD 30.47 million a year ago. Basic earnings per share from continuing operations was USD 0.09 compared to basic loss per share from continuing operations of USD 0.27 a year ago. Diluted earnings per share from continuing operations was USD 0.08 compared to diluted loss per share from continuing operations of USD 0.27 a year ago.